Immune-Onc Therapeutics
Dr. Zhiqiang An is a scientific advisor at Immune-Onc Therapeutics and a previous director at Merck. Zhiqiang has also worked as a scientist at Millennium Pharmaceuticals and as the Chief Scientific Officer at Epitomics - an Abcam Company. Dr. An received their PhD in Biology from Stanford University in 1995.
Zhiqiang An earned their post-doctoral degree in microbial genetics from the University of Wisconsin-Madison. Zhiqiang then went on to earn their Ph.D. in plant pathology from the University of Kentucky.
This person is not in the org chart
This person is not in any offices
Immune-Onc Therapeutics
Immune-Onc Therapeutics, Inc. (“Immune-Onc”) is a clinical-stage cancer immunotherapy company dedicated to the discovery and development of novel myeloid checkpoint inhibitors for cancer patients. Headquartered in Palo Alto, California, Immune-Onc has assembled a diverse team with deep expertise in drug development and proven track records of success at leading biotechnology companies.